dalteparin has been researched along with Venous Insufficiency in 4 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Venous Insufficiency: Impaired venous blood flow or venous return (venous stasis), usually caused by inadequate venous valves. Venous insufficiency often occurs in the legs, and is associated with EDEMA and sometimes with VENOUS STASIS ULCERS at the ankle.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nattokinase (NK) is a serine protease enzyme with fibrinolytic activity." | 3.01 | Data Recorded in Real Life Support the Safety of Nattokinase in Patients with Vascular Diseases. ( Cione, E; De Sarro, G; Di Mizio, G; Gallelli, G; Gallelli, L; Muraca, L; Palleria, C; Rubino, P; Salerno, M; Siniscalchi, A, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tarkovskiĭ, AA | 1 |
| Zudin, AM | 1 |
| Aleksandrova, ES | 1 |
| Gallelli, G | 1 |
| Di Mizio, G | 1 |
| Palleria, C | 1 |
| Siniscalchi, A | 1 |
| Rubino, P | 1 |
| Muraca, L | 1 |
| Cione, E | 1 |
| Salerno, M | 1 |
| De Sarro, G | 1 |
| Gallelli, L | 1 |
| Bayır, İ | 1 |
| Kemaloğlu, CA | 1 |
| Deniz, K | 1 |
| Fassiadis, N | 1 |
| Stavrianakis, C | 1 |
| Moghraby, OS | 1 |
| Gandhi, P | 1 |
| Smedley, FH | 1 |
1 trial available for dalteparin and Venous Insufficiency
| Article | Year |
|---|---|
Data Recorded in Real Life Support the Safety of Nattokinase in Patients with Vascular Diseases.
Topics: Adult; Aged; Aged, 80 and over; Enoxaparin; Female; Fibrinolytic Agents; Fondaparinux; Humans; Male; | 2021 |
3 other studies available for dalteparin and Venous Insufficiency
| Article | Year |
|---|---|
[Sequence of venous blood flow alterations in patients after recently endured acute thrombosis of lower-limb deep veins based on the findings of ultrasonographic duplex scanning].
Topics: Acute Disease; Adult; Anticoagulants; Enoxaparin; Fibrinolytic Agents; Follow-Up Studies; Humans; Le | 2009 |
Management of venous flap insufficiency: the role of low molecular weight heparin in salvage.
Topics: Animals; Enoxaparin; Free Tissue Flaps; Heparin; Heparin, Low-Molecular-Weight; Rats; Rats, Sprague- | 2022 |
Venous thromboembolism. Prophylaxis on a Saturday morning in a district hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bandages; Female; Fibrinolytic Agents; Guideline Adheren | 2002 |